Form 8-K - Current report:
SEC Accession No. 0001213900-21-021819
Filing Date
2021-04-16
Accepted
2021-04-16 06:19:19
Documents
2
Period of Report
2021-04-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea139580-8k_gxacqcorp.htm 8-K 33233
2 PRESS RELEASE OF GX ACQUISITION CORP., DATED APRIL 16, 2021 ea139580ex99-1_gxacqcorp.htm EX-99.1 27366
  Complete submission text file 0001213900-21-021819.txt   61713
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
GX Acquisition Corp. (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 21830058
SIC: 2834 Pharmaceutical Preparations